CareDx, Inc. - Common Stock (NQ:CDNA)

88.08 +16.56 (+23.15%)

Delayed Quote Updated: 12:37 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association

March 23, 2023

From CareDx, Inc.

Via Business Wire

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

March 10, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Analyst Expectations for CareDx's Future ↗

March 03, 2023

Via Benzinga

CareDx Earns Stock Downgrade Amid CMS Coverage Cuts Change Thesis ↗

March 03, 2023

Via Benzinga

CareDx's Return On Capital Employed Insights ↗

March 02, 2023

Via Benzinga

The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance

March 07, 2023

From CareDx, Inc.

Via Business Wire

CareDx Update Regarding Raymond James & Associates’ Conference

March 06, 2023

From CareDx, Inc.

Via Business Wire

Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday ↗

March 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference

March 06, 2023

From CareDx, Inc.

Via Business Wire

Earnings Outlook For CareDx ↗

February 24, 2023

Via Benzinga

Raymond James Maintains Strong Buy Rating for CareDx: Here's What You Need To Know ↗

January 31, 2023

Via Benzinga

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023 ↗

March 03, 2023

Via Benzinga

CareDx Comments on MolDX Publication of New Billing and Coding Article

March 03, 2023

From CareDx, Inc.

Via Business Wire

CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit

March 01, 2023

From CareDx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 28, 2023

Via Benzinga

Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday ↗

February 28, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Where CareDx Stands With Analysts ↗

January 31, 2023

Via Benzinga

Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 28, 2023

Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...

Via Benzinga

CareDx Reports Fourth Quarter and Full Year 2022 Results

February 27, 2023

From CareDx, Inc.

Via Business Wire

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting

February 22, 2023

From CareDx, Inc.

Via Business Wire

CareDx to Report Fourth Quarter and Full Year 2022 Financial Results

February 21, 2023

From CareDx, Inc.

Via Business Wire

CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings

February 16, 2023

From CareDx, Inc.

Via Business Wire

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

February 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 27, 2023

The growth-focused money manager is making moves.

Via The Motley Fool

JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice

January 26, 2023

From CareDx, Inc.

Via Business Wire

CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium

January 11, 2023

From CareDx, Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.